Health Care Up As Sector Seen Benefiting From Vaccine Push -- Health Care Roundup

Health-care companies rose as traders bet the sector would benefit from a global push on health-care vaccines.

GlaxoSmithKline and Vir Biotechnology said their Covid-19 antibody treatment retained effectiveness against the Omicron variant in laboratory studies, even as early data suggests that similar treatments work less well against the highly mutated strain. Shares of Vir rose sharply.

Pfizer Chief Executive Albert Bourla said the drugmaker could have done more to help improve low vaccination rates in poor countries, while pointing to some efforts to get supply to the countries.

 Write to Rob Curran at [e-mail] 

(END) Dow Jones Newswires

12-07-21 1729ET